Pacira Biosciences Inc. (pcrx 2.125 05/15/29)

13F holders, Q1 2026 (March 31)
3holders +2
2new positions
0sold out
$0.97avg. 13F price*

At the end of Q1 2026, 3 institutions reported holding Pacira Biosciences Inc. (pcrx 2.125 05/15/29) in their 13F filings, up 2 from Q4 2025. 2 opened new positions and 0 sold out. The largest holders were Absolute Investment Advisers, LLC ($8.7M), Ssi Investment Management LLC ($3.9M) and Cetera Investment Advisers ($23K).

Company
Pacira Biosciences Inc. (pcrx 2.125 05/15/29)
CUSIP
695127AJ9
Latest filing quarter
Q2 2026

History

Number of 13F holders

0123 Q2 2025: 1Q2 2025Q3 2025: 1Q3 2025Q4 2025: 1Q4 2025Q1 2026: 3Q1 2026Q2 2026: 3Q2 2026

Total Exit/New Position Q4 2025 → Q1 2026

InstitutionsTotal Value
New Positions2$3.9M
Exits0$0

All 13F filers, Q4 2025 → Q1 2026: 4,024,000 shares bought, net +4,024,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 3 holders

Absolute Investment Advisers, LLC 1.02% No change 9,000,000 $8.7M
Ssi Investment Management LLC 0.32% New 4,000,000 $3.9M
Cetera Investment Advisers 0.00% New 24,000 $23K

"% of holder's portfolio" is PACIRA BIOSCIENCES INC (PCRX 2.125 05/15/29)'s weight in each manager's 13F, not the share of Pacira Biosciences Inc. (pcrx 2.125 05/15/29) the manager owns.